These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22325054)

  • 1. Re: Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Teraa M; Sprengers RW; Leiner T; Verhaar MC
    Cell Transplant; 2012; 21(8):1803-4. PubMed ID: 22325054
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
    Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
    Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.
    Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG
    Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
    Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
    Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Middle-term outcome of autologous bone marrow mononuclear cells transplantation for treatment of lower limb ischemia].
    Gu Y; Qi L; Zhang J; Guo L; Li J; Zhang S; Yu H; Li X; Cui S; Chen B; Wu Y; Tong Z; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Mar; 23(3):341-4. PubMed ID: 19366150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of angiogenesis in rat ischemic limb by intramuscular implantation of mononuclear fraction cells from autologous bone marrow.
    Larionov PM; Chernyavskii AM; Novruzov RB; Lushnikova EL; Subbotin DV; Sergeevichev DS; Kuznetsova IV; Karas'kov AM; Nepomnyashchikh LM
    Bull Exp Biol Med; 2011 Feb; 150(4):530-4. PubMed ID: 22268058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia.
    Duong Van Huyen JP; Smadja DM; Bruneval P; Gaussem P; Dal-Cortivo L; Julia P; Fiessinger JN; Cavazzana-Calvo M; Aiach M; Emmerich J
    Mod Pathol; 2008 Jul; 21(7):837-46. PubMed ID: 18487998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
    Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
    Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.
    Tateishi-Yuyama E; Matsubara H; Murohara T; Ikeda U; Shintani S; Masaki H; Amano K; Kishimoto Y; Yoshimoto K; Akashi H; Shimada K; Iwasaka T; Imaizumi T;
    Lancet; 2002 Aug; 360(9331):427-35. PubMed ID: 12241713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia.
    Maione C; Botti C; Coppola CA; Silvestroni C; Lillo S; Schiavone V; Sica G; Sica V; Kumar V; Cobellis G
    Transplant Proc; 2013; 45(1):402-6. PubMed ID: 23375329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA).
    Walter DH; Krankenberg H; Balzer JO; Kalka C; Baumgartner I; Schlüter M; Tonn T; Seeger F; Dimmeler S; Lindhoff-Last E; Zeiher AM;
    Circ Cardiovasc Interv; 2011 Feb; 4(1):26-37. PubMed ID: 21205939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Dregelid regarding article, "Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease".
    Dregelid E
    Circ Cardiovasc Interv; 2011 Apr; 4(2):e12; author reply e13. PubMed ID: 21505158
    [No Abstract]   [Full Text] [Related]  

  • 18. Marked decrease of plasma VEGF after implantation of autologous bone marrow mononuclear cells in a patient with critical limb ischemia--a case report.
    Ozawa T; Kato K; Sanada H; Makiyama Y; Saigawa T; Souda S; Hashimoto S; Furukawa T; Toba K; Kodama M; Fujiwara H; Namura O; Hayashi J; Yoshimura N; Aizawa Y
    Angiology; 2006; 57(2):235-9. PubMed ID: 16518534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter by Dregelid regarding article, "Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)".
    Dregelid E
    Circ Cardiovasc Interv; 2011 Jun; 4(3):e18. PubMed ID: 21673319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.